| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| P. Kent Hawryluk | President CEO | 2026-03-13 | 18,500 | $28.41 | $525.66kBuy |
| P. Kent Hawryluk | President CEO | 2026-02-26 | 28,768 | $16.00 | $460.29kBuy |
| P. Kent Hawryluk | President CEO | 2025-10-24 | 182,859 | $3.25 | $594.29kBuy |
| P. Kent Hawryluk | President CEO | 2025-10-20 | 20,000 | $13.64 | $272.78kBuy |
| Steven L. Hoerter | Director | 2025-10-17 | 20,000 | $13.25 | $264.98kBuy |
| Patrick J. Heron | Director | 2025-09-26 | 666,666 | $18.00 | $12.00MBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Frazier Life Sciences Management LP | 14.00% | 6,652,013 | $213.66M | Institution |
| Patrick J. Heron | 10.99% | 5,219,440 | $167.65M | Insider |
| Orbimed Advisors LLC | 9.60% | 4,560,102 | $146.47M | Insider |
| Carl L. Gordon | 9.60% | 4,560,102 | $146.47M | Insider |
| Frazier Life Sciences X LP | 9.58% | 4,552,774 | $146.24M | Insider |
| Orbimed Advisors LLC | 8.28% | 3,935,203 | $126.40M | Institution |
| Nea Management Company LLC | 7.61% | 3,614,486 | $116.10M | Institution |
| Scott D. Sandell | 7.61% | 3,614,486 | $116.10M | Insider |
| Carmen Chang | 7.61% | 3,614,486 | $116.10M | Insider |
| Edward T. Mathers | 7.61% | 3,614,486 | $116.10M | Insider |